Merck's Keytruda wins FDA approval for a stubborn type of bladder cancer
Regeneron's rare bone disease drug delivers in phase 2 trial
Documents show Purdue sales reps misled physicians on drug's safety
Solid Biosciences restructuring to get halted gene therapy study back on track
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
